PillCam Colon Capsule Endoscopy for Ulcerative Colitis
1 other identifier
observational
20
0 countries
N/A
Brief Summary
Pillcam colon capsule (PCC) endoscopy is a novel strategy tool to inspect colon mucosa. The aim of the present study is to evaluate if PCC endoscopy is able to precisely investigate patients with ulcerative colitis and reach high consistency to conventional colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 20, 2011
CompletedFirst Posted
Study publicly available on registry
November 8, 2011
CompletedNovember 8, 2011
November 1, 2011
1 year
October 20, 2011
November 4, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the accuracy of PCC endoscopy in the survey of ulcerative colitis compared with conventional compared with conventional
the severity of patients investigated by PCC endoscopy and conventional colonoscopy the extent of evolved lesions extent investigated by PCC endoscopy and conventional colonoscopy the safety of PCC endoscopy course (eg: adverse events during bowel preparation and the course; the completion rate)
Secondary Outcomes (4)
the gastrointestinal transit time (transit time from ingestion to excretion), cecum arrival time (transit time from ingestion to the cecum), and colon residence time (transit time from the arrival in the cecum to excretion)
clinical data such as age, gender,chief complaint
the Mayo score of each case
the quality of colonic preparation
Eligibility Criteria
academic hospital endoscopist of digestive department
You may qualify if:
- Adult patients (aged 18-70)
- Ulcerative Colitis history
- Suffering from symptoms such as hematochezia, diarrhea or abdominal pain
You may not qualify if:
- Patients with a high risk for capsule retention (such as intestinal diverticula, acute abdominal pain without regular defecation indicating intestinal obstruction or a history of abdominal operation or intestinal reconstructed operation),
- Patients allergic to sodium phosphate or polyethylene glycol (PEG) solution,
- Patients with a history of Crohn's disease
- Patients with serious systematic diseases such as congestive heart failure, renal failure or severe liver disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
regular biopsy was taken during conventional colonoscopy according to the activity and position of ulcerative colitis involved.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zhi zheng Ge, MD. Ph.D
Clinical Professor of Gastroenterology Department, Shanghai Renji Hospital; Director, Head of Digestive Endoscopy Department, Shanghai Renji Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Shanghai Institute of Digestive Disease,Renji Hospital, Shanghai Jiao Tong University School of Medicine
Study Record Dates
First Submitted
October 20, 2011
First Posted
November 8, 2011
Study Start
July 1, 2009
Primary Completion
July 1, 2010
Study Completion
November 1, 2010
Last Updated
November 8, 2011
Record last verified: 2011-11